Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.40 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL906682 | 0.93 | ALDH1A1 (0.41) | ALDH1A1KMT2AAPOBEC3GMAPTEHMT2 | |
| SCHEMBL579460 | 0.92 | ALDH1A1 (0.53) | ALDH1A1KMT2AAPOBEC3GMAPTEHMT2 | |
| SCHEMBL5665047 | 0.87 | ALDH1A1 (0.58) | ALDH1A1KMT2AMAPTLMNASMN1; SMN2 | |
| SCHEMBL8579317 | 0.83 | ALDH1A1 (0.40) | ALDH1A1KMT2AAPOBEC3GMAPTEHMT2 | |
| SCHEMBL551390 | 0.82 | ALDH1A1 (0.44) | ALDH1A1KMT2AAPOBEC3GMAPTEHMT2 | |
| SCHEMBL18022125 | 0.81 | ALDH1A1 (0.45) | ALDH1A1KMT2AAPOBEC3GMAPTEHMT2 | |
| SCHEMBL321112 | 0.80 | LMNA (0.38) | ALDH1A1KMT2AAPOBEC3GMAPTEHMT2 | |
| SCHEMBL1655486 | 0.80 | LMNA (0.38) | ALDH1A1KMT2AAPOBEC3GMAPTEHMT2 | |
| SCHEMBL23512422 | 0.80 | ALDH1A1 (0.51) | ALDH1A1KMT2AAPOBEC3GMAPTEHMT2 | |
| SCHEMBL574826 | 0.79 | HDAC1 (0.37) | ALDH1A1KMT2AAPOBEC3GMAPTEHMT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2442 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260043066-A1 | COMPOSITIONS AND METHODS RELATED TO KETHOXAL DERIVATIVES | THE UNIVERSITY OF CHICAGO (US) | 2026-02-12 | — | — | US | claimed |
| WO-2025222300-A1 | ATRIAL NATRIURETIC PEPTIDE CONSTRUCTS FOR TARGETED PAYLOAD DELIVERY TO NPR-C EXPRESSING CELLS | PROTEINQURE INC. (CA) | 2025-10-30 | — | — | WO | claimed |
| US-12453768-B2 | Vaccines for in vivo expression of nucleic acids and methods of using the same | ORBIS HEALTH SOLUTIONS, LLC (US) | 2025-10-28 | — | — | US | claimed |
| US-20250302983-A1 | Saponin Conjugates | SAPREME TECHNOLOGIES B.V. (NL) | 2025-10-02 | — | — | US | claimed |
| US-20250295745-A1 | CROSS-LINKED TUMOR LYSATE SPHERICAL NUCLEIC ACIDS AS CANCER VACCINES | NORTHWESTERN UNIVERSITY | 2025-09-25 | — | — | US | claimed |
| EP-4452331-B1 | TARGETED SAPONIN-NUCLEIC ACID CONJUGATES FOR TREATMENT OF MUSCLE WASTING DISORDERS | SAPREME TECH BV (NL) | 2025-08-06 | — | — | EP | claimed |
| US-12379387-B2 | Engineered particles as red blood cell mimics and compositions containing same for hematology | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-08-05 | — | — | US | claimed |
| US-12330138-B2 | Surface functionalised materials for sampling biological molecules | JONES, Paul Antonio (GB) | 2025-06-17 | — | — | US | claimed |
| US-20250146912-A1 | FIXATIVE SOLUTIONS AND METHODS FOR USING SAME | STICHTING RADBOUD UNIVERSITEIT (NL) | 2025-05-08 | — | — | US | claimed |
| EP-3765188-B1 | SURFACE FUNCTIONALISED MATERIALS FOR SAMPLING BIOLOGICAL MOLECULES | JONES PAUL ANTONIO (GB) | 2025-04-16 | — | — | EP | claimed |
| WO-2000050101-A1 | INTRAOCULAR LENS IMPLANTS FOR THE PREVENTION OF SECONDARY CATARACTS | BAUSCH & LOMB SURGICAL, INC. (US) | 2000-08-31 | — | — | WO | claimed |
| EP-0972194-A2 | COMPOSITIONS AND METHODS FOR INHIBITING LIGHT-INDUCED INACTIVATION OF BIOLOGICAL REAGENTS | BIOSITE DIAGNOSTICS INC. (US) | 2000-01-19 | — | — | EP | claimed |
| WO-1998045705-A2 | COMPOSITIONS AND METHODS FOR INHIBITING LIGHT-INDUCED INACTIVATION OF BIOLOGICAL REAGENTS | BIOSITE DIAGNOSTICS INCORPORATED (US) | 1998-10-15 | — | — | WO | claimed |
| EP-0550663-B1 | MODIFIED ANTIBODIES WITH CONTROLLED CLEARANCE TIME | TECHNICLONE INC (US) | 1998-01-21 | — | — | EP | claimed |
| EP-0783894-A1 | Antibodies modified at two separate sites | TECHNICLONE, INC. (US) | 1997-07-16 | — | — | EP | claimed |
| EP-0701448-A4 | AMPLIFICATION OF THE VITAMIN B 12? UPTAKE SYSTEM USING POLYMERS | BIOTECH AUSTRALIA PTY LTD (AU) | 1997-01-02 | — | — | EP | claimed |
| EP-0701448-A1 | AMPLIFICATION OF THE VITAMIN B 12? UPTAKE SYSTEM USING POLYMERS | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 1996-03-20 | — | — | EP | claimed |
| WO-1994027641-A1 | AMPLIFICATION OF THE VITAMIN B12 UPTAKE SYSTEM USING POLYMERS | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 1994-12-08 | — | — | WO | claimed |
| EP-0382781-B1 | COMPOSITION FOR TREATING CANCERS CHARACTERIZED BY OVER-EXPRESSION OF THE C-FMS PROTO-ONCOGENE | GENETICS INSTITUTE, INC. (US) | 1993-09-29 | — | — | EP | claimed |
| US-5084556-A | Composition of M-CSF conjugated to cytotoxic agents and a method for treating cancers characterized by over-expression of the c-fms proto-oncogene | GENETICS INSTITUTE, INC. (US) | 1992-01-28 | — | — | US | claimed |